Biểu đồ giá cổ phiếu PPBT
PPBT Dự đoán giá cổ phiếu
Purple Biotech Ltd
$4.12
5.49%
$0.21
Khi đóng cửa: May 08, 16:00:00 GMT-4
$3.95
-4.24%
$-0.17
Phiên sau giờ: May 08, 20:00:00 GMT-4
Quay lại
Purple Biotech Ltd (PPBT) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$3.91
Giá mở cửa
$4.08
Phạm vi ngày
$3.95 - $4.19
Phạm vi 52 tuần
$3.6 - $29
Khối lượng
3.3K
Khối lượng trung bình
13.3K
Tỷ suất cổ tức
--
EPS (TTM)
-54.00
Vốn hóa thị trường
$3.6M
Purple Biotech Ltd. là gì?
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 10 full-time employees. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
